Sign in
8-K

Current Report

Aligos Therapeutics, Inc. Filed Acc 0001193125-26-166987

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d50981d8k.htm…